Search Results 441-450 of 17417 for albinism
This is a study where a new drug, called GSK4771261 is being tested. Neither the study doctors, study staff or participants will be aware of what treatment is ...
Eliminating bias in medicine and science; Giving access to Mayo Clinic's knowledge and services to patients, addressing barriers; Achieving true belonging among ...
Find out more about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.
This study is to evaluate the safety and efficacy of simtuzumab (GS-6624) in adults with compensated cirrhosis due to Non-Alcoholic Steatohepatitis (NASH). It ...
Learn more about the symptoms and treatment of this rare, noncancerous (benign) tumor that develops in the jaw.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Research in Dr. Jurk's Biology of Aging and Age-Related Diseases Lab is examining how senescence contributes to various diseases related to aging.
Pilot Study to Assess the Validity of "Liquid Biopsy" to Improve Diagnosis, Prognostic Assessment and Disease Monitoring in Patients Undergoing Liver Transplant ...
About this study. The purpose of these phase I/II trial studies is to analyze the side effects and best dose of liposomal irinotecan and rucaparib when ...
In addition, information on the effectiveness of ATTR amyloidosis treatments, including eplontersen, which is a ligand-conjugated antisense oligonucleotide gene ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.